Vericel Anticipates Strong Second Half for MACI
The company grew in the high-single digits in 2Q22, representing the highest MACI revenue total outside of fourth quarters since launch. Aug 05, 2022
NuVasive Sees Increased Volume and Demand in Second Quarter
The company grew in the mid-single digits for 2Q22 as it benefitted from increased volume in newer product categories. Aug 04, 2022
Zimmer Biomet Exceeds Expectations with Second Quarter Performance
The company grew in the low single digits for 2Q22 despite market headwinds and raised its full-year 2022 guidance. Aug 03, 2022
Smith+Nephew Held Back by Strategic Execution and Supply Chain
The company declined in the mid-single digits in 2Q22 as disruption in China exacerbated existing execution and supply problems. Aug 01, 2022
CONMED Backorders Grow Amid Supply Constraints
The company grew in the double digits for 2Q22 with modest declines in the U.S. offset by strength in Europe, Canada and Latin America. Jul 29, 2022
Stryker’s Results Mixed in Choppy Second Quarter
The company grew in the low single digits for 2Q22 as it contends with slower OUS markets and evolving dynamics in robotics sales. Jul 28, 2022
DePuy Synthes’ OUS Challenges Bring Second Quarter Declines
The company's second-quarter sales declined in the low single digits as it faced a strong prior year comparison and OUS disruption. Jul 20, 2022
Orthopedic Funding Announcements Concentrated in Spine Segment
This month’s chart segments the 239 unique funding announcements we’ve covered since 2016, ranging from IPOs to small grants. Jul 18, 2022
OMTEC 2022 Keynote: Market in Uncharted Territory Say Ortho Execs
Executives from some of the largest orthopedic companies gathered at OMTEC to discuss the operating environment and trends. Jun 27, 2022
State of the Orthopedic Industry 2022
The webinar provides company performance analysis and essential takeaways for all segments of the orthopedic market in 2021. Jun 24, 2022
